The PI3K/Akt pathway is particularly relevant in breast cancer, where PIK3CA alterations occur in roughly 21% to 47% of cases [56,59,72,73,74,75,76,77,78,79,80,81,82], making it the most frequently mutated oncogene in this cancer type. This evidence concerns the gene PIK3CB and cancer.